Physician profile
Cara Scott
NPI 1184325037
$882.06
in general payments reported to CMS, 2019-2025
11 companies · $94.57 in 2025
The $94.57 reported for 2025 was less than what a typical Obstetrics & Gynecology (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $271 · 2024: $516 · 2025: $94.57.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $842 · Education: $40.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $842.01 |
| Education | $40.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $262.46 | 2023-2024 | Lo Loestrin Fe, Ubrelvy, Orilissa |
| Astellas Pharma US INC | $153.69 | 2023-2024 | Veozah |
| Mayne Pharma Commercial LLC | $108.29 | 2023-2025 | |
| Pfizer INC. | $96.13 | 2023-2024 | |
| Millicent US INC | $62.46 | 2024 | Femring, Intrarosa |
| Shield Therapeutics INC | $58.27 | 2023-2025 | Accrufer |
| Globus Medical, INC. | $41.08 | 2025 | Senza |
| Exact Sciences Corporation | $37.68 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Mycovia Pharmaceuticals, INC. | $24.43 | 2023 | Vivjoa |
| Sage Therapeutics, LLC | $20.47 | 2024 | |
| Exeltis, USA INC. | $17.10 | 2024 | Slynd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cara Scott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.